The use of trastuzumab deruxtecan (Enhertu), a new HER2-targeting antibody-drug conjugate, doubled progression-free survival compared…
New research by the Daffodil Centre, at Cancer Council NSW and the University of Sydney,…
By Dr Jennifer Cohen,(1,2), Ms Thomasin Powell(1), Associate Professor Pandora Patterson(1,3) As lockdowns ease in…
Today’s episode is all about robots! Yes, the wonderful folks over at Canteen have a…
Bishal Gyawali, Queen’s University, Ontario Where should investment be made today in order to save…
The bottom of the ocean is full of mysteries but scientists have recently uncovered one…
A breast cancer patient’s perspective on their physical well-being can provide a better indication of…
Ryan Layer, University of Colorado Boulder Most of the roughly 40 trillion cells of your…
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or…
Nearly one million people in the United States are affected by Lynch syndrome – a…